Studies using exogenous GLP-1 infusion in humans demonstrated reduced energy intake, reduced appetite and decreased brain responses to food anticipation and consumption without direct changes in energy expenditure, and data strongly suggest that body-weight loss ensuing from GLP-1R agonist administration in humans largely reflects reductions in food intake [24, 25]
For patients under 16, IV hydration may be considered on a case-by-case basis following evaluation by our in-house provider to ensure safety and appropriateness
Absolute contraindications: Active malignancy IGF-1 is mitogenic and promotes cell growth Pregnancy Disruption of the hypothalamic-pituitary axis by injury, tumor, or surgery Hypersensitivity to tesamorelin or mannitol (an excipient in the formulation) A qualified metabolic provider will screen for all of these before initiating therapy
Keep being you, Morgan.Wayne MillerApril 26, 2025Absolutely amazing place with an amazing staff
However, with this has come pill fatigue and a desire for alternative formats
